Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, March 30 '25)

 


    Ann Intern Med

  1. GRANWEHR BP
    CBT and rehabilitation improved long COVID symptoms.
    Ann Intern Med. 2025;178:JC28.
    PubMed         Abstract available

  2. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015.
    PubMed         Abstract available


    Antiviral Res

  3. KUO YS, Chiang PC, Kuo CY, Huang CG, et al
    Inhibition of influenza A virus proliferation in mice via universal RNA interference.
    Antiviral Res. 2025 Mar 25:106149. doi: 10.1016/j.antiviral.2025.106149.
    PubMed         Abstract available


    Arch Virol

  4. YE QY, Jiang ZT, Jiang Y, Cai JW, et al
    Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant.
    Arch Virol. 2025;170:88.
    PubMed         Abstract available


    BMC Pediatr

  5. SHAN J, Yang X, Wang T
    Epidemiology of influenza from 2017 to 2022 in a national children's regional medical center.
    BMC Pediatr. 2025;25:240.
    PubMed         Abstract available

  6. WARNCKE K, Hofer SE, von Sengbusch S, Ermer U, et al
    Did smoking behavior change in adolescents and young adults with and without diabetes during the COVID-19 pandemic? A cohort study from the DPV registry.
    BMC Pediatr. 2025;25:236.
    PubMed         Abstract available


    Epidemiol Infect

  7. CHEN C, Chen D, Du Y, Jiang D, et al
    Global patterns and trends in deaths of influenza-associated lower respiratory infections from 1990 to 2019.
    Epidemiol Infect. 2025;153:e49.
    PubMed         Abstract available


    J Gen Virol

  8. HANKINSON J, Young D, Wignall-Fleming EB, Lukoszek R, et al
    The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1.
    J Gen Virol. 2025;106.
    PubMed         Abstract available


    J Infect Dis

  9. CAO W, Su W, Song X, Ma L, et al
    Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    J Infect Dis. 2025 Mar 25:jiaf075. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  10. KRAMMER F, Hermann E, Rasmussen AL
    Highly pathogenic avian influenza H5N1: history, current situation, and outlook.
    J Virol. 2025 Mar 27:e0220924. doi: 10.1128/jvi.02209.
    PubMed         Abstract available

  11. YU L, Jiang Y, Rang H, Wang X, et al
    Restriction of influenza A virus replication by host DCAF7-CRL4B axis.
    J Virol. 2025 Mar 27:e0013325. doi: 10.1128/jvi.00133.
    PubMed         Abstract available

  12. LANG Y, Shi L, Roy S, Gupta D, et al
    Detection of antibodies against influenza A viruses in cattle.
    J Virol. 2025 Mar 25:e0213824. doi: 10.1128/jvi.02138.
    PubMed         Abstract available


    Lancet

  13. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed         Abstract available


    PLoS One

  14. YAN Z, Wang L
    The relationship between sleep disorder and mental health in athletes and its mediating role: a cross-sectional study.
    PLoS One. 2025;20:e0319813.
    PubMed         Abstract available

  15. ANDERSON D, Chapman J, Domingues J, Bobadilla G, et al
    The Healthy Minds, Thriving Kids Project: Educator perspectives on relevance and potential impact of a mental health skill building program.
    PLoS One. 2025;20:e0305450.
    PubMed         Abstract available

  16. SARKER MJA, Hasan M, Kabir A, Haque A, et al
    Leveraging artificial intelligence to assess the impact of COVID-19 on the teacher-student relationship in higher education.
    PLoS One. 2025;20:e0317567.
    PubMed         Abstract available

  17. FONSECA JFD, Silva SO, Silva LCMA, Camara RPPOA, et al
    Effect of the online module on leadership in knowledge acquisition among nursing students: A randomized controlled study protocol.
    PLoS One. 2025;20:e0320208.
    PubMed         Abstract available

  18. IMAI H, Suzuki J, Mizuno T, Takahashi S, et al
    The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study.
    PLoS One. 2025;20:e0318803.
    PubMed         Abstract available

  19. ALKHARABSHEH A, Alshurafa S, Alhanbali S, Garadat S, et al
    Personal Listening device (PLD) usage among University Students and their audiometric profile during the shift to online learning post COVID-19.
    PLoS One. 2025;20:e0319665.
    PubMed         Abstract available

  20. TRUNG CTT, Dat NT, Teh CJ, Tee PK, et al
    Psychological capital and mental health problems among the unemployed in the post-COVID-19 era: Self- esteem as a moderator.
    PLoS One. 2025;20:e0319555.
    PubMed         Abstract available

  21. WATSON DL, Bonett S, Meanley S, Wood SM, et al
    Acceptability and feasibility of HIV self-testing integration into publicly-funded HIV prevention services: Perspectives from HIV testing agency staff that provide HIV testing services to sexual and gender minority youth in Philadelphia County.
    PLoS One. 2025;20:e0320290.
    PubMed         Abstract available

  22. LIN GSS, Tan WW, Chua KH, Kim JE, et al
    Adapting new norms: A mixed-method study exploring mental well-being challenges in dental technology education.
    PLoS One. 2025;20:e0320602.
    PubMed         Abstract available

  23. KODANI Y, Nagami S, Yokozeki A, Fukunaga S, et al
    Current status of Tele-speech language therapy by type and support for patients with post-stroke aphasia: A scoping review.
    PLoS One. 2025;20:e0319805.
    PubMed         Abstract available

  24. WEISE V, Buechl VCS, Mack JT, Garthus-Niegel S, et al
    Prospective associations between psychosocial work stress, work-privacy conflict, and relationship satisfaction of young parents during the COVID-19 pandemic: The mediating role of symptoms of depression and anger/hostility.
    PLoS One. 2025;20:e0320022.
    PubMed         Abstract available

  25. LIU J, Zhou K, Meng C, Liu Z, et al
    Roxadustat effectiveness versus ESAs in peritoneal dialysis patients during the COVID-19 pandemic: A retrospective study.
    PLoS One. 2025;20:e0320536.
    PubMed         Abstract available

  26. NIKBAKHT F, Heidarian Miri H, Mosafarkhani E, Sharifjafari F, et al
    Role of COVID-19 infection status on the prediction of future infection: Immunity or susceptibility.
    PLoS One. 2025;20:e0317959.
    PubMed         Abstract available

  27. MAKOANA KM, Naidoo CM, Zubair MS, Motshudi MC, et al
    Integration of metabolomics and chemometrics with in-silico and in-vitro approaches to unravel SARS-Cov-2 inhibitors from South African plants.
    PLoS One. 2025;20:e0320415.
    PubMed         Abstract available

  28. CHOI H, Marinescu I
    Work attendance anxiety, precarious work schedules, and job satisfaction of essential retail workers during the early COVID-19 pandemic.
    PLoS One. 2025;20:e0318586.
    PubMed         Abstract available

  29. SANTOS CVBD, Coelho LE, Goedert GT, Luz PM, et al
    Disability-adjusted life years associated with COVID-19 in Brazil, 2020.
    PLoS One. 2025;20:e0319941.
    PubMed         Abstract available

  30. DIABY M, Bangoura ST, Hounmenou CG, Kadio KJO, et al
    Exploratory analysis of poultry workers' knowledge and practices Regarding highly pathogenic avian influenza in Guinea.
    PLoS One. 2025;20:e0320890.
    PubMed         Abstract available

  31. MARTIN AF, Smith LE, Brooks SK, Stein MV, et al
    The impact of self-isolation on psychological wellbeing in adults and how to reduce it: A systematic review.
    PLoS One. 2025;20:e0310851.
    PubMed         Abstract available

  32. BIERRENBACH AL, Ranzani OT
    Evaluating the accuracy of ICD-10 codes for syncytial respiratory virus diagnosis in hospitalized patients: A record-linkage study (2022-2023).
    PLoS One. 2025;20:e0319436.
    PubMed         Abstract available

  33. PARK LS, Jaung R, Park JJ, Song C, et al
    Examining access to and trust in sources of COVID-19 information among CALD Asian communities in New Zealand.
    PLoS One. 2025;20:e0319326.
    PubMed         Abstract available


    Vaccine

  34. HARALAMBIEVA IH, Ratishvili T, Goergen KM, Grill DE, et al
    Effect of lymphocyte miRNA expression on influenza vaccine-induced immunity.
    Vaccine. 2025;55:127023.
    PubMed         Abstract available


    Virology

  35. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    PubMed         Abstract available


    Virus Res

  36. MYERS ML, Conlon MT, Gallagher JR, Woolfork DD, et al
    Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.
    Virus Res. 2025 Mar 24:199563. doi: 10.1016/j.virusres.2025.199563.
    PubMed         Abstract available

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...